Financial burden of tuberculosis diagnosis and treatment for patients in Ethiopia: a systematic review and meta-analysis.
Dawit Getachew AssefaZewdu Gashu DememewEden Dagnachew ZelekeTsegahun ManyazewalAhmed BedruPublished in: BMC public health (2024)
Irrespective of a national policy of free TB service, more than half of TB patients are suffering catastrophic costs due to drug-sensitive pulmonary TB in Ethiopia and most of the patients spend a lot of money during the pre-diagnosis period and intensive phase, but declined drastically over time. Active case-finding, digital adherence interventions, community-based treatment, and comprehensive health insurance coverage have the potential to minimize the financial burden of TB diagnosis and treatment.
Keyphrases
- end stage renal disease
- mycobacterium tuberculosis
- ejection fraction
- health insurance
- newly diagnosed
- chronic kidney disease
- healthcare
- peritoneal dialysis
- prognostic factors
- mental health
- public health
- emergency department
- patient reported outcomes
- adipose tissue
- insulin resistance
- weight loss
- quality improvement
- antiretroviral therapy